Cardlytics Statistics
Total Valuation
Cardlytics has a market cap or net worth of $208.83 million. The enterprise value is $359.58 million.
Important Dates
The next confirmed earnings date is Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Cardlytics has 49.84 million shares outstanding. The number of shares has increased by 25.99% in one year.
| Current Share Class | 49.84M |
| Shares Outstanding | 49.84M |
| Shares Change (YoY) | +25.99% |
| Shares Change (QoQ) | +13.43% |
| Owned by Insiders (%) | 2.31% |
| Owned by Institutions (%) | 56.94% |
| Float | 42.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.58 |
| Forward PS | 0.62 |
| PB Ratio | 0.99 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 1.06.
| Current Ratio | 1.77 |
| Quick Ratio | 1.71 |
| Debt / Equity | 1.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.68 |
Financial Efficiency
Return on equity (ROE) is -68.74% and return on invested capital (ROIC) is -7.86%.
| Return on Equity (ROE) | -68.74% |
| Return on Assets (ROA) | -6.26% |
| Return on Capital (ROIC) | -7.86% |
| Revenue Per Employee | $703,724 |
| Profits Per Employee | -$353,304 |
| Employee Count | 434 |
| Asset Turnover | 0.52 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.79% in the last 52 weeks. The beta is 1.62, so Cardlytics's price volatility has been higher than the market average.
| Beta (5Y) | 1.62 |
| 52-Week Price Change | -69.79% |
| 50-Day Moving Average | 3.64 |
| 200-Day Moving Average | 7.76 |
| Relative Strength Index (RSI) | 61.20 |
| Average Volume (20 Days) | 605,664 |
Short Selling Information
The latest short interest is 7.61 million, so 15.26% of the outstanding shares have been sold short.
| Short Interest | 7.61M |
| Short Previous Month | 8.29M |
| Short % of Shares Out | 15.26% |
| Short % of Float | 18.00% |
| Short Ratio (days to cover) | 11.97 |
Income Statement
In the last 12 months, Cardlytics had revenue of $305.42 million and -$153.33 million in losses. Loss per share was -$3.61.
| Revenue | 305.42M |
| Gross Profit | 134.95M |
| Operating Income | -58.49M |
| Pretax Income | -153.33M |
| Net Income | -153.33M |
| EBITDA | -33.03M |
| EBIT | -58.49M |
| Loss Per Share | -$3.61 |
Full Income StatementBalance Sheet
The company has $71.25 million in cash and $222.00 million in debt, giving a net cash position of -$150.75 million or -$3.02 per share.
| Cash & Cash Equivalents | 71.25M |
| Total Debt | 222.00M |
| Net Cash | -150.75M |
| Net Cash Per Share | -$3.02 |
| Equity (Book Value) | 210.03M |
| Book Value Per Share | 4.25 |
| Working Capital | 80.73M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.06 million and capital expenditures -$1.26 million, giving a free cash flow of -$10.32 million.
| Operating Cash Flow | -9.06M |
| Capital Expenditures | -1.26M |
| Free Cash Flow | -10.32M |
| FCF Per Share | -$0.21 |
Full Cash Flow StatementMargins
Gross margin is 44.18%, with operating and profit margins of -19.15% and -50.20%.
| Gross Margin | 44.18% |
| Operating Margin | -19.15% |
| Pretax Margin | -50.20% |
| Profit Margin | -50.20% |
| EBITDA Margin | -10.81% |
| EBIT Margin | -19.15% |
| FCF Margin | -8.35% |
Dividends & Yields
Cardlytics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.99% |
| Shareholder Yield | -25.99% |
| Earnings Yield | -73.43% |
| FCF Yield | -4.94% |
Analyst Forecast
The average price target for Cardlytics is $5.90, which is 40.81% higher than the current price. The consensus rating is "Hold".
| Price Target | $5.90 |
| Price Target Difference | 40.81% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cardlytics has an Altman Z-Score of -1.79 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.79 |
| Piotroski F-Score | 5 |